Global Usher Syndrome Threapeutics Market Research Report 2024

Report ID: 1977402 | Published Date: Mar 2026 | No. of Page: 62 | Base Year: 2025 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Usher Syndrome Threapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 NT-501
        1.2.3 QRX-411
        1.2.4 QRX-421
        1.2.5 SAR-421869
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Usher Syndrome Threapeutics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Usher Syndrome Threapeutics Market Perspective (2018-2029)
    2.2 Usher Syndrome Threapeutics Growth Trends by Region
        2.2.1 Global Usher Syndrome Threapeutics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Usher Syndrome Threapeutics Historic Market Size by Region (2018-2023)
        2.2.3 Usher Syndrome Threapeutics Forecasted Market Size by Region (2024-2029)
    2.3 Usher Syndrome Threapeutics Market Dynamics
        2.3.1 Usher Syndrome Threapeutics Industry Trends
        2.3.2 Usher Syndrome Threapeutics Market Drivers
        2.3.3 Usher Syndrome Threapeutics Market Challenges
        2.3.4 Usher Syndrome Threapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Usher Syndrome Threapeutics Players by Revenue
        3.1.1 Global Top Usher Syndrome Threapeutics Players by Revenue (2018-2023)
        3.1.2 Global Usher Syndrome Threapeutics Revenue Market Share by Players (2018-2023)
    3.2 Global Usher Syndrome Threapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Usher Syndrome Threapeutics Revenue
    3.4 Global Usher Syndrome Threapeutics Market Concentration Ratio
        3.4.1 Global Usher Syndrome Threapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Usher Syndrome Threapeutics Revenue in 2022
    3.5 Usher Syndrome Threapeutics Key Players Head office and Area Served
    3.6 Key Players Usher Syndrome Threapeutics Product Solution and Service
    3.7 Date of Enter into Usher Syndrome Threapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Usher Syndrome Threapeutics Breakdown Data by Type
    4.1 Global Usher Syndrome Threapeutics Historic Market Size by Type (2018-2023)
    4.2 Global Usher Syndrome Threapeutics Forecasted Market Size by Type (2024-2029)
5 Usher Syndrome Threapeutics Breakdown Data by Application
    5.1 Global Usher Syndrome Threapeutics Historic Market Size by Application (2018-2023)
    5.2 Global Usher Syndrome Threapeutics Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Usher Syndrome Threapeutics Market Size (2018-2029)
    6.2 North America Usher Syndrome Threapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Usher Syndrome Threapeutics Market Size by Country (2018-2023)
    6.4 North America Usher Syndrome Threapeutics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Usher Syndrome Threapeutics Market Size (2018-2029)
    7.2 Europe Usher Syndrome Threapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Usher Syndrome Threapeutics Market Size by Country (2018-2023)
    7.4 Europe Usher Syndrome Threapeutics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Usher Syndrome Threapeutics Market Size (2018-2029)
    8.2 Asia-Pacific Usher Syndrome Threapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Usher Syndrome Threapeutics Market Size by Region (2018-2023)
    8.4 Asia-Pacific Usher Syndrome Threapeutics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Usher Syndrome Threapeutics Market Size (2018-2029)
    9.2 Latin America Usher Syndrome Threapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Usher Syndrome Threapeutics Market Size by Country (2018-2023)
    9.4 Latin America Usher Syndrome Threapeutics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Usher Syndrome Threapeutics Market Size (2018-2029)
    10.2 Middle East & Africa Usher Syndrome Threapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Usher Syndrome Threapeutics Market Size by Country (2018-2023)
    10.4 Middle East & Africa Usher Syndrome Threapeutics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Amgen Inc
        11.1.1 Amgen Inc Company Detail
        11.1.2 Amgen Inc Business Overview
        11.1.3 Amgen Inc Usher Syndrome Threapeutics Introduction
        11.1.4 Amgen Inc Revenue in Usher Syndrome Threapeutics Business (2018-2023)
        11.1.5 Amgen Inc Recent Development
    11.2 Editas Medicine Inc
        11.2.1 Editas Medicine Inc Company Detail
        11.2.2 Editas Medicine Inc Business Overview
        11.2.3 Editas Medicine Inc Usher Syndrome Threapeutics Introduction
        11.2.4 Editas Medicine Inc Revenue in Usher Syndrome Threapeutics Business (2018-2023)
        11.2.5 Editas Medicine Inc Recent Development
    11.3 ProQR Therapeutics NV
        11.3.1 ProQR Therapeutics NV Company Detail
        11.3.2 ProQR Therapeutics NV Business Overview
        11.3.3 ProQR Therapeutics NV Usher Syndrome Threapeutics Introduction
        11.3.4 ProQR Therapeutics NV Revenue in Usher Syndrome Threapeutics Business (2018-2023)
        11.3.5 ProQR Therapeutics NV Recent Development
    11.4 Sanofi
        11.4.1 Sanofi Company Detail
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Usher Syndrome Threapeutics Introduction
        11.4.4 Sanofi Revenue in Usher Syndrome Threapeutics Business (2018-2023)
        11.4.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Usher Syndrome Threapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of NT-501
    Table 3. Key Players of QRX-411
    Table 4. Key Players of QRX-421
    Table 5. Key Players of SAR-421869
    Table 6. Key Players of Others
    Table 7. Global Usher Syndrome Threapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Usher Syndrome Threapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Usher Syndrome Threapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Usher Syndrome Threapeutics Market Share by Region (2018-2023)
    Table 11. Global Usher Syndrome Threapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Usher Syndrome Threapeutics Market Share by Region (2024-2029)
    Table 13. Usher Syndrome Threapeutics Market Trends
    Table 14. Usher Syndrome Threapeutics Market Drivers
    Table 15. Usher Syndrome Threapeutics Market Challenges
    Table 16. Usher Syndrome Threapeutics Market Restraints
    Table 17. Global Usher Syndrome Threapeutics Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Usher Syndrome Threapeutics Market Share by Players (2018-2023)
    Table 19. Global Top Usher Syndrome Threapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Usher Syndrome Threapeutics as of 2022)
    Table 20. Ranking of Global Top Usher Syndrome Threapeutics Companies by Revenue (US$ Million) in 2022
    Table 21. Global 5 Largest Players Market Share by Usher Syndrome Threapeutics Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Usher Syndrome Threapeutics Product Solution and Service
    Table 24. Date of Enter into Usher Syndrome Threapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Usher Syndrome Threapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Usher Syndrome Threapeutics Revenue Market Share by Type (2018-2023)
    Table 28. Global Usher Syndrome Threapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Usher Syndrome Threapeutics Revenue Market Share by Type (2024-2029)
    Table 30. Global Usher Syndrome Threapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Usher Syndrome Threapeutics Revenue Market Share by Application (2018-2023)
    Table 32. Global Usher Syndrome Threapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Usher Syndrome Threapeutics Revenue Market Share by Application (2024-2029)
    Table 34. North America Usher Syndrome Threapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. North America Usher Syndrome Threapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 36. North America Usher Syndrome Threapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Europe Usher Syndrome Threapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Europe Usher Syndrome Threapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 39. Europe Usher Syndrome Threapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Asia-Pacific Usher Syndrome Threapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Asia-Pacific Usher Syndrome Threapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 42. Asia-Pacific Usher Syndrome Threapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 43. Latin America Usher Syndrome Threapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Latin America Usher Syndrome Threapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Latin America Usher Syndrome Threapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Middle East & Africa Usher Syndrome Threapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 47. Middle East & Africa Usher Syndrome Threapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 48. Middle East & Africa Usher Syndrome Threapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 49. Amgen Inc Company Detail
    Table 50. Amgen Inc Business Overview
    Table 51. Amgen Inc Usher Syndrome Threapeutics Product
    Table 52. Amgen Inc Revenue in Usher Syndrome Threapeutics Business (2018-2023) & (US$ Million)
    Table 53. Amgen Inc Recent Development
    Table 54. Editas Medicine Inc Company Detail
    Table 55. Editas Medicine Inc Business Overview
    Table 56. Editas Medicine Inc Usher Syndrome Threapeutics Product
    Table 57. Editas Medicine Inc Revenue in Usher Syndrome Threapeutics Business (2018-2023) & (US$ Million)
    Table 58. Editas Medicine Inc Recent Development
    Table 59. ProQR Therapeutics NV Company Detail
    Table 60. ProQR Therapeutics NV Business Overview
    Table 61. ProQR Therapeutics NV Usher Syndrome Threapeutics Product
    Table 62. ProQR Therapeutics NV Revenue in Usher Syndrome Threapeutics Business (2018-2023) & (US$ Million)
    Table 63. ProQR Therapeutics NV Recent Development
    Table 64. Sanofi Company Detail
    Table 65. Sanofi Business Overview
    Table 66. Sanofi Usher Syndrome Threapeutics Product
    Table 67. Sanofi Revenue in Usher Syndrome Threapeutics Business (2018-2023) & (US$ Million)
    Table 68. Sanofi Recent Development
    Table 69. Research Programs/Design for This Report
    Table 70. Key Data Information from Secondary Sources
    Table 71. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Usher Syndrome Threapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Usher Syndrome Threapeutics Market Share by Type: 2022 VS 2029
    Figure 3. NT-501 Features
    Figure 4. QRX-411 Features
    Figure 5. QRX-421 Features
    Figure 6. SAR-421869 Features
    Figure 7. Others Features
    Figure 8. Global Usher Syndrome Threapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Usher Syndrome Threapeutics Market Share by Application: 2022 VS 2029
    Figure 10. Clinic Case Studies
    Figure 11. Hospital Case Studies
    Figure 12. Others Case Studies
    Figure 13. Usher Syndrome Threapeutics Report Years Considered
    Figure 14. Global Usher Syndrome Threapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Usher Syndrome Threapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Usher Syndrome Threapeutics Market Share by Region: 2022 VS 2029
    Figure 17. Global Usher Syndrome Threapeutics Market Share by Players in 2022
    Figure 18. Global Top Usher Syndrome Threapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Usher Syndrome Threapeutics as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Usher Syndrome Threapeutics Revenue in 2022
    Figure 20. North America Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Usher Syndrome Threapeutics Market Share by Country (2018-2029)
    Figure 22. United States Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Usher Syndrome Threapeutics Market Share by Country (2018-2029)
    Figure 26. Germany Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Usher Syndrome Threapeutics Market Share by Region (2018-2029)
    Figure 34. China Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Usher Syndrome Threapeutics Market Share by Country (2018-2029)
    Figure 42. Mexico Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Usher Syndrome Threapeutics Market Share by Country (2018-2029)
    Figure 46. Turkey Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Usher Syndrome Threapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Amgen Inc Revenue Growth Rate in Usher Syndrome Threapeutics Business (2018-2023)
    Figure 49. Editas Medicine Inc Revenue Growth Rate in Usher Syndrome Threapeutics Business (2018-2023)
    Figure 50. ProQR Therapeutics NV Revenue Growth Rate in Usher Syndrome Threapeutics Business (2018-2023)
    Figure 51. Sanofi Revenue Growth Rate in Usher Syndrome Threapeutics Business (2018-2023)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen Inc
Editas Medicine Inc
ProQR Therapeutics NV
Sanofi
Frequently Asked Questions
Usher Syndrome Threapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Usher Syndrome Threapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Usher Syndrome Threapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports